Tritonpoint Wealth »

Halozyme Therapeutics shares owned by Tritonpoint Wealth

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Tritonpoint Wealth from 13F filings

Historical chart of Tritonpoint Wealth investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Tritonpoint Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Tritonpoint Wealth

Quarter filed Position value Share count Share price at filing
2024-03-31 $250k 6.8k 37.01
2023-12-31 $250k 6.8k 36.96